← Eichor
Study identifier: NCT07327489 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Condition: Cancer · Immunotherapy · Advanced Solid Tumors Cancer  ·  Sponsor: Elephas

PhaseN/A
Planned participants2000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (8)

Mercy Hospital - FTSFort Smith, Arkansas, United StatesRecruiting
Frederick Health HospitalFrederick, Maryland, United StatesRecruiting
Mercy Hospital - SPGSpringfield, Missouri, United StatesRecruiting
Mercy Hospital - SouthSt Louis, Missouri, United StatesRecruiting
Mercy Hospital -STLSt Louis, Missouri, United StatesRecruiting
Mercy Hospital - OKCOklahoma City, Oklahoma, United StatesRecruiting
JPS Health NetworkForth Worth, Texas, United StatesRecruiting
Baylor Scott and White BiorepositoryTemple, Texas, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07327489